Search

Your search keyword '"Balduini, C"' showing total 541 results

Search Constraints

Start Over You searched for: Author "Balduini, C" Remove constraint Author: "Balduini, C"
541 results on '"Balduini, C"'

Search Results

151. Evidence for a glycoprotein IIb-IIIa- and aggregation-independent mechanism of phosphatidylinositol 3',4'-bisphosphate synthesis in human platelets.

152. Interactions between different corneal proteoglycans

153. Self-digestion of human erythrocyte membranes. Role of adenosine triphosphate and glutathione

155. Biosynthesis of glycosaminoglycans in bovine cornea. The effect of uridine diphosphate xylose

156. Uridine diphosphate glucose dehydrogenase from cornea and epiphysial-plate cartilage

159. Membrane processes in myotonic dystrophy during in vitro aging of erythrocytes

165. The European Hematology Association Roadmap for European Hematology Research: a consensus document

167. Outcomes of Patients Hospitalized with Community-Acquired, Health Care-Associated, and Hospital-Acquired Pneumonia

169. Anagrelide in essential thrombocythemia: A retrospective analysis of 220 patients

180. Multilineage dysplasia without increased blasts identifies a poor prognosis subset of myelodysplastic syndromes.

185. Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register

186. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study

187. Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients

188. Pattern of in-hospital changes in drug use in the older people from 2010 to 2016

189. The European Hematology Association Roadmap for European Hematology Research: a consensus document

190. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study

191. MYH9-related disease: Five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations

192. SiO2-B2O3 xerogels: The problem of boron leaching

193. Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant.

194. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings.

195. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

196. International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country

197. SiO2-B2O3 xerogels: The problem of boron leaching

198. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations

199. Dominant inheritance of a novel integrin 3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families

200. The Gi-coupled P2Y12 Receptor Regulates Diacylglycerol-mediated Signaling in Human Platelets

Catalog

Books, media, physical & digital resources